← Open Payments lookup

DAVINA UCHEGBU: Open Payments

NPI 1841846342 · SACRAMENTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,279 in 42 payments from 11 companies in 2025. Trend: 2023 $1,310 · 2024 $1,376 · 2025 $1,279

Food & beverage: $1,279
CompanyPaymentsAmount
ABBVIE INC.21$499
Otsuka America Pharmaceutical, Inc.4$166
Janssen Pharmaceuticals, Inc2$142
Neurocrine BioSciences, Inc.3$130
E.R. Squibb & Sons, L.L.C.1$121
Teva Pharmaceuticals USA, Inc.3$57
Supernus Pharmaceuticals, Inc.3$51
Vanda Pharmaceuticals Inc.2$43
Lundbeck LLC1$32
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$22

Products named: VRAYLAR, REXULTI, INGREZZA, INVEGA SUSTENNA, COBENFY, UZEDY, Qelbree, HETLIOZ.

Industry payments across CA — which companies pay providers there.